<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05065749</url>
  </required_header>
  <id_info>
    <org_study_id>ASQT012021</org_study_id>
    <nct_id>NCT05065749</nct_id>
  </id_info>
  <brief_title>Clinical Results of Asqelio Trifocal Diffractive Intraocular Lens</brief_title>
  <official_title>Clinical Results of Asqelio Trifocal Diffractive Intraocular Lens</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AST Products, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AST Products, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to evaluate the clinical outcomes six months after implantation of the&#xD;
      trifocal diffractive intraocular lens Asqelio Trifocal IOL TFLIO130C in healthy subjects&#xD;
      submitted to non-traumatic cataract surgery.&#xD;
&#xD;
      This clinical performance will be assessed in terms of refractive error, visual performance&#xD;
      at different distances, incidence of adverse events and complications following implantation,&#xD;
      and patient satisfaction.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">October 2021</start_date>
  <completion_date type="Anticipated">April 2022</completion_date>
  <primary_completion_date type="Anticipated">February 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Adverse events</measure>
    <time_frame>Six months after implantation</time_frame>
    <description>Percentage of subjects with adverse events (Ocular and Not Ocular, Severe and Not Severe), including secondary surgical procedures</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Refraction</measure>
    <time_frame>Six months after implantation</time_frame>
    <description>Manifest refraction both monocular and binocularly using subjective methods</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Uncorrected visual acuity for distance (4m)</measure>
    <time_frame>Six months after implantation</time_frame>
    <description>Monocular visual acuity for distance (4m), without any additional correction, using ETDRS vision chart</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Best-corrected visual acuity for distance (4m)</measure>
    <time_frame>Six months after implantation</time_frame>
    <description>Monocular visual acuity for distance (4m), with the best correction for distance, using ETDRS vision chart</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Uncorrected visual acuity for intermediate</measure>
    <time_frame>Six months after implantation</time_frame>
    <description>Monocular visual acuity for intermediate distance (60cm), without any additional correction, using ETDRS vision chart</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Best-corrected visual acuity for intermediate</measure>
    <time_frame>Six months after implantation</time_frame>
    <description>Monocular visual acuity for intermediate distance (60cm), with the best correction for distance, using ETDRS vision chart</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Uncorrected visual acuity for near</measure>
    <time_frame>Six months after implantation</time_frame>
    <description>Monocular visual acuity for near distance (40cm), without any additional correction, using ETDRS vision chart</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Best-corrected visual acuity for near</measure>
    <time_frame>Six months after implantation</time_frame>
    <description>Monocular visual acuity for near distance (40cm), with the best correction for distance, using ETDRS vision chart</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Contrast sensitivity function (CSF)</measure>
    <time_frame>Six months after implantation</time_frame>
    <description>CSF with best correction, with and without induced glare, using the Clinical Trial Suite</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Defocus curve</measure>
    <time_frame>Six months after implantation</time_frame>
    <description>Defocus curve of visual performance varying the stimulus vergence from -4.0 D to +1.0 D in 0.5 D steps with the best correction for distance</description>
  </secondary_outcome>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Cataract</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients 50 years of age or older submitted to cataract surgery and implanted with the&#xD;
        Asqelio Trifocal IOL TFLIO130C according to regular clinical practice&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients submitted to cataract surgery and implanted with Asqelio Trifocal IOL&#xD;
             TFLIO130C&#xD;
&#xD;
          -  Patients signing a consent form&#xD;
&#xD;
          -  Patients seeking spectacle-independence following surgery&#xD;
&#xD;
          -  IOL power between +5.00 and +34.00 D&#xD;
&#xD;
          -  Transparent intraocular media, except for the cataract prior to surgery, in both eyes&#xD;
&#xD;
          -  Postoperatory potential visual acuity of 20/25 or better.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Preoperatory corneal astigmatism greater than 0.75D&#xD;
&#xD;
          -  Patients not providing informed consent&#xD;
&#xD;
          -  Previous corneal surgery or trauma&#xD;
&#xD;
          -  Irregular cornea (i.e. keratoconus)&#xD;
&#xD;
          -  Choroidal hemorrhage&#xD;
&#xD;
          -  Microophthalmos&#xD;
&#xD;
          -  Severe corneal dystrophy&#xD;
&#xD;
          -  Uncontrolled or medically controlled glaucoma&#xD;
&#xD;
          -  Clinically significant macular changes&#xD;
&#xD;
          -  Severe concomitant ocular disease&#xD;
&#xD;
          -  Not age-related cataract&#xD;
&#xD;
          -  Severe optic nerve atrophy&#xD;
&#xD;
          -  Diabetic retinopathy&#xD;
&#xD;
          -  Ambyopia&#xD;
&#xD;
          -  Extremely shallow anterior chamber&#xD;
&#xD;
          -  Severe chronic uveitis&#xD;
&#xD;
          -  Pregnant or lactating&#xD;
&#xD;
          -  Rubella&#xD;
&#xD;
          -  Mature/Dense cataract sifficulting preoperative fundus assessment&#xD;
&#xD;
          -  Previous retinal detachment&#xD;
&#xD;
          -  Concurrent participation in other investigation using drugs or clinical devices&#xD;
&#xD;
          -  Expecting ocular surgery within the study period&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>María Cobo</last_name>
    <phone>+34 965141500</phone>
    <email>maria.cobo@oftalvist.es</email>
  </overall_contact>
  <location>
    <facility>
      <name>OftalVist Jerez de la Frontera</name>
      <address>
        <city>Jerez de la Frontera</city>
        <state>Cádiz</state>
        <zip>11408</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ramón Ruiz Mesa, MD</last_name>
      <phone>+34 901010190</phone>
    </contact>
    <investigator>
      <last_name>Ramón Ruiz Mesa, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Julia Blanch Ruiz, OD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>OftalVist Alicante</name>
      <address>
        <city>Alicante</city>
        <zip>03015</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pedro Tañá Rivero, MD</last_name>
      <phone>+34 965141500</phone>
    </contact>
    <investigator>
      <last_name>Pedro Tañá Rivero, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Salvador Aguilar Córcoles, OD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cristina Tello Elordi, OD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 23, 2021</study_first_submitted>
  <study_first_submitted_qc>September 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 4, 2021</study_first_posted>
  <last_update_submitted>October 1, 2021</last_update_submitted>
  <last_update_submitted_qc>October 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cataract surgery</keyword>
  <keyword>intraocular lens</keyword>
  <keyword>multifocal refractive correction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

